TGFB1 and cholangiocarcinoma: An in vitro study further suggested that targeting cytokine receptors of IL‐10 and TGF‐β on DCs enhanced the cytolytic activity of DC‐activated CD8+ T cells against CCA cell lines,118 supporting this strategy as a means to boost ICI efficacy in ‘cold’ tumors.